Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01161992 · ClinicalTrials.gov registry record
Genomics of Primary Sclerosing Cholangitis (PSC)
A clinical trial of Primary Sclerosing Cholangitis (PSC), sponsored by Mayo Clinic.
- Completed
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT01161992: Completed study of Primary Sclerosing Cholangitis (PSC), sponsored by Mayo Clinic.
NCT01161992 is a study of Primary Sclerosing Cholangitis (PSC) that has completed, run by Mayo Clinic. The registered enrollment target is 1,500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01161992, a study of Primary Sclerosing Cholangitis (PSC), has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Sclerosing Cholangitis (PSC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PSC. This study is being done to investigate whether genes make people more likely to develop PSC. Discovery of these genes will help us to better understand how PSC developes and subsequently, to apply new approaches for its prevention, diagnosis and treatment.
Primary Outcome
Adult chronic cholestatic liver diseases, such as Primary Sclerosing Cholangitis (PSC), are progressive liver disorders of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PSC. This study is being done to investigate whether genes (the inherited genetic material passed from parents to their children) make people more likely to develop PSC. Discover
Conditions Studied
Interventions
- GENETIC Genetic Analysis
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2002-03 |
| Est. Completion | 2025-07-31 |
What the finished NCT01161992 record still lists
NCT01161992 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Primary Sclerosing Cholangitis (PSC) appearing as the primary indexed condition, and to 1 intervention - of which Genetic Analysis is the first listed.
NCT01161992 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01161992 about?
NCT01161992 is a clinical study titled "Genomics of Primary Sclerosing Cholangitis (PSC)". Primary Sclerosing Cholangitis (PSC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PSC. This study is being done...
What is the current status of trial NCT01161992?
This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2002-03. Estimated completion is 2025-07-31.
What conditions does trial NCT01161992 study?
This clinical trial studies the following conditions: Primary Sclerosing Cholangitis (PSC).
What interventions are being tested in trial NCT01161992?
The interventions under investigation include: Genetic Analysis (GENETIC).
Who is sponsoring clinical trial NCT01161992?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01161992 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Sclerosing Cholangitis (PSC)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia